Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 50,500 shares, a decrease of 51.1% from the February 28th total of 103,300 shares. Based on an average daily volume of 609,700 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on RBGLY shares. Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Royal Bank of Canada reaffirmed an “outperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, Reckitt Benckiser Group presently has an average rating of “Buy”.
View Our Latest Analysis on RBGLY
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Increases Dividend
The company also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 11th will be given a dividend of $0.2909 per share. The ex-dividend date of this dividend is Friday, April 11th. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.19.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- What is Put Option Volume?
- MarketBeat Week in Review – 03/24 – 03/28
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.